Multiple CAR-T Cell Therapy Targeting AML

Clinical trial NCT04010877 · RECRUITING

Trial details

NCT number: NCT04010877
Sponsor: Shenzhen Geno-Immune Medical Institute
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2025-08-01
Primary completion: 2028-07-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.